Related Experiment Video
Updated: Jun 22, 2025

Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Published on: June 13, 2020
Microbiome-driven anticancer therapy: A step forward from natural products
Yunxuan Guan1, Di Wu1, Hui Wang1
1State Key Laboratory of Systems Medicine for Cancer, Center for Single-Cell Omics, School of Public Health Shanghai Jiao Tong University School of Medicine Shanghai China.
Abstract:
Human microbiomes, considered as a new emerging and enabling cancer hallmark, are increasingly recognized as critical effectors in cancer development and progression. Manipulation of microbiome revitalizing anticancer therapy from natural products shows promise toward improving cancer outcomes. Herein, we summarize our current understanding of the human microbiome-driven molecular mechanisms impacting cancer progression and anticancer therapy. We highlight the potential translational and clinical implications of natural products for cancer prevention and treatment by developing targeted therapeutic strategies as adjuvants for chemotherapy and immunotherapy against tumorigenesis. The challenges and opportunities for future investigations using modulation of the microbiome for cancer treatment are further discussed in this review.
Insights
The human microbiome influences cancer development and treatment. Natural products offer a promising approach to enhance anticancer therapies by targeting these microbes.
Area of Science:
- Oncology
- Microbiology
- Pharmacology
Background:
- The human microbiome is recognized as a key factor in cancer development and progression.
- Microbiome manipulation is a promising strategy to enhance anticancer therapies.
Purpose of the Study:
- To review the molecular mechanisms of microbiome involvement in cancer.
- To highlight the potential of natural products in cancer prevention and treatment.
- To discuss future directions for microbiome-based cancer therapies.
Main Methods:
- Literature review of current research on the human microbiome and cancer.
- Analysis of molecular mechanisms linking microbiome and cancer progression.
- Evaluation of natural products as therapeutic adjuvants.
Main Results:
- The human microbiome plays a critical role in cancer development and progression.
- Natural products can be utilized to modulate the microbiome for improved anticancer outcomes.
- Targeted strategies involving natural products show potential as adjuncts to chemotherapy and immunotherapy.
Conclusions:
- Modulating the human microbiome holds significant promise for cancer prevention and treatment.
- Natural products offer a viable avenue for developing targeted cancer therapies.
- Further research is needed to fully explore the therapeutic potential of microbiome modulation in oncology.
More Related Videos
07:28Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
Published on: October 29, 2020
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Drugs that Stabilize Microtubules
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Tumor Microenvironment